GlaxoSmithKline settles $105 million 'off-label' advertising dispute with 45 states
Wednesday, June 4, 2014 - 15:20
in Mathematics & Economics
Matt BradwellSAN FRANCISCO, June 4 (UPI) -- GlaxoSmithKline has reached a $105 million settlement with 45 U.S. states over alleged illegal marketing of antidepressant and asthma drugs.